Mechanisms of cardiac fibrosis in hypertension

J Díez - The Journal of Clinical Hypertension, 2007 - Wiley Online Library
Changes in the composition of cardiac tissue develop in hypertensive patients with left
ventricular hypertrophy (ie, hypertensive heart disease) and lead to structural remodeling of …

Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease

J Díez, A González, B López, R Querejeta - Nature clinical practice …, 2005 - nature.com
Abstract Changes in the composition of cardiac tissue develop in arterial hypertension and
lead to structural remodeling of the myocardium. Structural remodeling is the consequence …

Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

MP Ocaranza, I Godoy, JE Jalil, M Varas… - …, 2006 - Am Heart Assoc
The early and long-term effects of coronary artery ligation on the plasma and left ventricular
angiotensin-converting enzyme (ACE and ACE2) activities, ACE and ACE2 mRNA levels …

Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis

MP Ocaranza, J Moya, V Barrientos… - Journal of …, 2014 - journals.lww.com
Background: Little is known about the biological effects of angiotensin-(1–9), but available
evidence shows that angiotensin-(1–9) has beneficial effects in preventing/ameliorating …

Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions

G Díaz-Araya, R Vivar, C Humeres, P Boza… - Pharmacological …, 2015 - Elsevier
Cardiac fibroblasts (CF) not only modulate extracellular matrix (ECM) proteins homeostasis,
but also respond to chemical and mechanical signals. CF express a variety of receptors …

Substrate stiffness-regulated matrix metalloproteinase output in myocardial cells and cardiac fibroblasts: implications for myocardial fibrosis

J Xie, Q Zhang, T Zhu, Y Zhang, B Liu, J Xu, H Zhao - Acta biomaterialia, 2014 - Elsevier
Cardiac fibrosis, an important pathological feature of structural remodeling, contributes to
ventricular stiffness, diastolic dysfunction, arrhythmia and may even lead to sudden death …

Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1–9) through an AT2R and Akt-dependent mechanism

E Mendoza-Torres, JA Riquelme, A Vielma… - Pharmacological …, 2018 - Elsevier
Abstract Angiotensin-(19), a peptide of the non-classical renin angiotensin system, has been
shown to prevent and revert hypertension and cardiac hypertrophy. We hypothetized that …

Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease

É Larouche‐Lebel, KA Loughran… - Journal of veterinary …, 2019 - Wiley Online Library
Background Angiotensin‐converting enzyme 2 (ACE2) is a homologue of angiotensin‐
converting enzyme (ACE) and produces angiotensin peptides (APs), such as angiotensin 1 …

TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway

HN Chen, DJ Wang, MY Ren, QL Wang… - Molecular biology reports, 2012 - Springer
We wished to elucidate a potential role of the tumor necrosis factor-like weak inducer of
apoptosis (TWEAK)/fibroblast growth factor-inducible molecule 14 (Fn14) axis in myocardial …

Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?

S Kany, B Reissmann, A Metzner… - Cardiovascular …, 2021 - academic.oup.com
The prevalence and economic burden of atrial fibrillation (AF) are predicted to more than
double over the next few decades. In addition to anticoagulation and treatment of …